The health ministry has given a go ahead to initiate the preparatory work for the inclusion of the indigenously-developed, needle-free jab in the national Covid inoculation drive.
Zydus Cadila’s COVID-19 vaccination ZyCov-D is approved by India’s drug regulatory for individuals older than 12 years it will only be given to adults in the national anti-coronavirus vaccination program according to sources on Sunday. The health ministry has given a go ahead to initiate the preparatory work for the inclusion of the indigenously-developed, needle-free jab in the national Covid inoculation drive and it can be introduced in the programme anytime soon.
The ministry has already made an order with an Ahmedabad-based company for one crore doses of vaccine.
“ZyCov-D, which has been cleared by India’s drug regulator for those aged 12 years and above, will be given only to adults as of now under the national Covid vaccination drive,” an official source stated.
The Union Health Minister Mansukh Mandaviya on Thursday said the government is not looking to rush the process of administering Covid vaccines to infants and any decision regarding this will be in accordance with the opinions of experts.
The doctor said that children are not being given COVID-19 vaccines in large numbers anywhere around the globe, even though it is being introduced in certain countries in a restricted manner.
“About vaccinating the children, we will take a decision based on expert opinion. We have decided to think and evaluate before going ahead with vaccinating children as they are the future of our country and we need to tread with caution in this matter,” Mandaviya declared.
In the meantime, a comprehensive program to immunise children, including creating the priority list of comorbidities being developed in the National Technical Advisory Group on Immunisation (NTAGI).
ZyCov-D was the initial Covid vaccine approved by India’s drug regulator to allow the vaccination of children who are 12 years old and over.
For the use in emergency approval granted to Bharat Biotech’s Covaxin within the age range of 2 to 18 years , it is approved by DCGI Drugs Controller General of India (DCGI) It is currently under expert advice and evaluation, sources from the DCGI stated.
To administer ZyCov-D to people who are adults, frontline workers, and vaccinators will be given with a brief instruction on how to use the needle-free applicator in setting.
In the present, everyone over the age of 18 is eligible to receive Covid vaccination.
Drug company Zydus Cadila on the 8th of November reported that it had been given an instruction to provide one million doses Covid vaccine, ZyCoV, in order to supply the Indian government for Rs $265 for each dose.